rs367669306
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_005219.5(DIAPH1):āc.1964C>Gā(p.Pro655Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000568 in 1,545,202 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.00029 ( 0 hom., cov: 26)
Exomes š: 0.00060 ( 10 hom. )
Consequence
DIAPH1
NM_005219.5 missense
NM_005219.5 missense
Scores
3
7
8
Clinical Significance
Conservation
PhyloP100: 8.93
Genes affected
DIAPH1 (HGNC:2876): (diaphanous related formin 1) This gene is a homolog of the Drosophila diaphanous gene, and has been linked to autosomal dominant, fully penetrant, nonsyndromic sensorineural progressive low-frequency hearing loss. Actin polymerization involves proteins known to interact with diaphanous protein in Drosophila and mouse. It has therefore been speculated that this gene may have a role in the regulation of actin polymerization in hair cells of the inner ear. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.009348184).
BP6
Variant 5-141573886-G-C is Benign according to our data. Variant chr5-141573886-G-C is described in ClinVar as [Likely_benign]. Clinvar id is 542368.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.000291 (44/151448) while in subpopulation SAS AF= 0.00755 (36/4770). AF 95% confidence interval is 0.0056. There are 0 homozygotes in gnomad4. There are 30 alleles in male gnomad4 subpopulation. Median coverage is 26. This position pass quality control queck.
BS2
High AC in GnomAd4 at 44 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DIAPH1 | NM_005219.5 | c.1964C>G | p.Pro655Arg | missense_variant | 16/28 | ENST00000389054.8 | NP_005210.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DIAPH1 | ENST00000389054.8 | c.1964C>G | p.Pro655Arg | missense_variant | 16/28 | 5 | NM_005219.5 | ENSP00000373706 | A2 | |
DIAPH1 | ENST00000518047.5 | c.1937C>G | p.Pro646Arg | missense_variant | 15/27 | 5 | ENSP00000428268 | P4 | ||
DIAPH1 | ENST00000647433.1 | c.1964C>G | p.Pro655Arg | missense_variant | 16/29 | ENSP00000494675 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000297 AC: 45AN: 151338Hom.: 0 Cov.: 26
GnomAD3 genomes
AF:
AC:
45
AN:
151338
Hom.:
Cov.:
26
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00147 AC: 221AN: 149862Hom.: 4 AF XY: 0.00200 AC XY: 157AN XY: 78464
GnomAD3 exomes
AF:
AC:
221
AN:
149862
Hom.:
AF XY:
AC XY:
157
AN XY:
78464
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000598 AC: 833AN: 1393754Hom.: 10 Cov.: 37 AF XY: 0.000835 AC XY: 573AN XY: 686390
GnomAD4 exome
AF:
AC:
833
AN:
1393754
Hom.:
Cov.:
37
AF XY:
AC XY:
573
AN XY:
686390
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000291 AC: 44AN: 151448Hom.: 0 Cov.: 26 AF XY: 0.000406 AC XY: 30AN XY: 73960
GnomAD4 genome
AF:
AC:
44
AN:
151448
Hom.:
Cov.:
26
AF XY:
AC XY:
30
AN XY:
73960
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
94
Asia WGS
AF:
AC:
23
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 12, 2019 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2022 | DIAPH1: BP4, BS2 - |
Autosomal dominant nonsyndromic hearing loss 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
DIAPH1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 25, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Autosomal dominant nonsyndromic hearing loss 1;C5567650:Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 24, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;.;T;.;T;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
T;T;T;T;T;T
MetaRNN
Benign
T;T;T;T;T;T
MetaSVM
Uncertain
D
MutationAssessor
Benign
L;.;.;.;.;.
MutationTaster
Benign
D;D;D;D;D;D;D;D
PrimateAI
Benign
T
PROVEAN
Uncertain
N;.;N;N;N;N
REVEL
Uncertain
Sift
Uncertain
D;.;D;T;T;D
Sift4G
Uncertain
D;.;D;D;D;D
Polyphen
D;.;.;.;.;.
Vest4
MutPred
Loss of glycosylation at P655 (P = 0.0029);Loss of glycosylation at P655 (P = 0.0029);.;.;Loss of glycosylation at P655 (P = 0.0029);.;
MVP
MPC
0.12
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at